Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study

Lancet

Volumn 359, Issue 9313, 2002, Pages 1173-1177

  Choi, Hyon K ^a   Hernán, Miguel A ^b   Seeger, John D ^b,c   Robins, James M ^b   Wolfe, Frederick ^d,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Ingenix Inc   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^e ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS;

EID: 0037029418     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08213-2     Document Type: Article

References (30)

1. Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study
2. Cause of death in rheumatoid arthritis
3. The mortality of rheumatoid arthritis
4. Cardiovascular mortality in patients with rheumatoid arthritis
5. Methotrexate and emerging therapies
6. Measurement of patient outcome in arthritis
7. Measuring health status in arthritis: The arthritis impact measurement scales
8. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
9. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
10. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis: A thirty-six-week, double-blind trial
11. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
12. Marginal structural models to estimate the joint causal effect of nonrandomized treatments
13. Analysis of methotrexate treatment effect in a longitudinal observational study: Utility of cluster analysis
14. Mortality predictors among 263 patients with rheumatoid arthritis
15. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures
16. Premature mortality in patients with rheumatoid arthritis: Evolving concepts
17. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
18. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well
19. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden
20. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Follow up after a mean of 13.3 years
21. Atherosclerosis-an inflammatory disease
22. A tale of two diseases: Atherosclerosis and rheumatoid arthritis
23. Adhesion molecules in rheumatoid arthritis
24. Starving the synovium: Angiogenesis and inflammation in rheumatoid arthritis
25. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes
26. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
27. Damage in systemic lupus erythematosus and its association with corticosteroids
28. Recent improvements in survival in patients with rheumatoid arthritis: Better outcomes or different study designs?
29. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
30. Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: Patient, order and observer variation